Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer-Reference-Cited by-同舟云学术

Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer

Published:2017-12 Issue: Volume:63 Page:30-39
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Janes Holly,Brown Marshall D.,Crager Michael R.,Miller Dave P.,Barlow William E.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference50 articles.

1. Evaluating markers for selecting a patient's treatment;Song;Biometrics,2004

2. Measuring the performance of markers for guiding treatment decisions;Janes;Ann. Intern. Med.,2011

3. Development and validation of biomarker classifiers for treatment selection;Simon;J. Stat. Plan. Infer.,2008

4. Issues in clinical trial design for tumor marker studies;Sargent;Semin. Oncol.,2002

5. Evaluating the efficiency of targeted designs for randomized clinical trials;Simon;Clin. Cancer Res.,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential;BMC Rheumatology;2021-07-02

2. Developing a predictive signature for two trial endpoints using the cross-validated risk scores method;Biostatistics;2021-06-24

3. On evaluating how well a biomarker can predict treatment response with survival data;Pharmaceutical Statistics;2020-01-13

4. 21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for Breast Cancer Patients with Positive Lymph Nodes;Scientific Reports;2019-09-11